Conference Material
|
Video
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
Yatskevich N
Share
Share
Similar Content
Loading...
Loading...
Loading...
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus | Conference Material / Video | MSF Science Portal
Countries
Belarus
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
Languages
English
DOI
10.57740/7dx0-kq64
Published Date
07 Jun 2023
Conference
MSF Scientific Day International 2023